CAR NK Cells Target Cancer and Autoimmunity
October 21, 2026
mRNA nanoparticles reprogram NK cells in vivo, inducing tumor remissions and reducing autoimmune liver damage in mice.
2 min read
False
Advertisement
October
Analytical Champions: Robert Wethman
October 21, 2026
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
6 min read
Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells
October 21, 2026
The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice
2 min read
How Genomics Is Personalizing Drug Discovery
October 20, 2026
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
4 min read
Musings from The Power List: Piers Ingram
October 20, 2026
Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and how artificial intelligence can shape the next generation of medicines
4 min read
Gene Therapy Approach Shows Promise for Hydrocephalus
October 20, 2026
Researchers develop AAV-based method to target cerebrospinal fluid production, revealing new insights into postnatal neurogenesis
2 min read
Inside Kindeva’s New Sterile Fill-Finish Facility
October 20, 2026
John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner
5 min read
Making Clinical Trial Labels More Accessible
October 19, 2026
Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial information
5 min read
SRSF1 Gene Delivery Extends Lifespan in Aged Mice
October 19, 2026
An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of cellular aging without erasing cell identity
2 min read
Three Targets, One CAR T Therapy
October 19, 2026
First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma
3 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs
Power List